| Previous Section | Index | Home Page |
26 Oct 2004 : Column 1193W—continued
Doctors (Training Costs)
Mr. Burstow: To ask the Secretary of State for Health what the average cost of training a doctor was in the last period for which figures are available. [192792]
Mr. Hutton:
In the period between entry to medical school and full registration, it is estimated that training a doctor costs between £200,000 and £250,000. Doctors generally continue training after full registration. As the
26 Oct 2004 : Column 1194W
duration and nature of post-registration training varies greatly, and as service and training costs are closely related, it is not possible to provide a meaningful estimate of the total cost of training.
EMIS System
Mrs. Anne Campbell: To ask the Secretary of State for Health what guidance he has given to general practitioners who do not wish to change clinical system under the National Programme for IT and who wish to carry on using the EMIS system. [192767]
Mr. Hutton: The Department's policy with regard to local choice about information technology (IT) provision remains as stated in the guidance agreed jointly with the British Medical Association. Each general practitioner practice should have a choice of more than one system so long as these have been accredited against national standards and can deliver the required functionality. Guidance published on the national programme for IT (NPfIT) website makes it clear that existing suppliers play an important role in current and future national health service IT service provision.
Local service providers have also been informed of the NPfIT position that GPs must not be forced to change system, and individual practices will continue to be supported where they have expressed a wish not to begin migrating in the short term to the preferred local system.
Glycogen Storage Disease
Mr. Boris Johnson: To ask the Secretary of State for Health how many recorded in-patient episodes of glycogen storage disease type one there have been in each year since 1989, broken down by primary care trust. [192663]
Miss Melanie Johnson: Counts of finished consultant episodes (FCEs) for glycogen storage disease by strategic health authority (SHA) of residence in England NHS hospitals for 1996–97 to 2002–03 are shown in the table. Comparable data prior to 1996–97 are not available centrally, nor is information giving counts of episodes specific to glycogen storage disease type one. It is not possible to provide figures by primary care trust due to the risk of breaching patient confidentiality.
Notes:
1. Diagnosis (primary diagnosis)
The primary diagnosis is the first of up to 14 (seven prior to 2002–03) diagnosis fields in the Hospital Episode Statistics (HES) data set and provides the main reason why the patient was in hospital.
2. Finished Consultant Episode (FCE)
An FCE is defined as a period of admitted patient care under one consultant within one healthcare provider. Please note that the figures do not represent the number of patients, as a person may have more than one episode of care within the year.
3. Grossing
Figures are grossed for both coverage and missing/invalid clinical data, except for 2002–03, which are not yet adjusted for shortfalls.
Source:
Hospital Episode Statistics (HES), Department of Health.
26 Oct 2004 : Column 1195W
Health Services (York)
Hugh Bayley: To ask the Secretary of State for Health how many patients have been treated at the NHS walk-in centre in York in each year since it opened. [191155]
Miss Melanie Johnson: Recorded attendances each year at York national health service walk-in centre since its opening on 24 April 2000 are shown in the table. However, the figures for 2002 are incomplete as data for July, October and November were not provided to the Department.
| Number of attendances | |
|---|---|
| 2000 | 10,276 |
| 2001 | 27,241 |
| 2002 | 25,129 |
| 2003 | 39,027 |
| 2004 (To date) | 28,985 |
Health Spending (Islington, North)
Jeremy Corbyn: To ask the Secretary of State for Health what the average per capita spending on (a) primary care, (b) mental health and (c) hospital care in Islington North constituency was in each year since 1996–97. [194009]
Dr. Ladyman:
The information is not available in the format requested. Expenditure per weighted head of the population in the North Central London Strategic Health Authority (SHA) area, which includes the constituency of Islington North, has increased from £623.57 in 1997–98 to £1,190.39 in 2002–03. This does
26 Oct 2004 : Column 1196W
not represent the total expenditure per head, as an element of health expenditure cannot be identified by SHA area.
Hepatitis C
Mr. Luff: To ask the Secretary of State for Health (1) what assessment his Department has made of the treatment rates of hepatitis C; [193387]
(2) if he will make it his policy to conduct research on treatment rates for hepatitis C in other EU countries. [193388]
Miss Melanie Johnson: We do not collect information centrally on the number of patients receiving national health service treatment for hepatitis C. We are putting arrangements in place to improve access to treatments recommended by the National Institute for Clinical Excellence (NICE), including antiviral drug therapy for hepatitis C. This will include the provision of data on hospital prescribing of NICE-recommended drugs to allow strategic health authorities to compare their own treatment rates with the national distribution and to take any necessary action locally.
We have no current plans to conduct research on hepatitis C treatment rates in other European Union countries.
HER2
Dame Marion Roe:
To ask the Secretary of State for Health (1) what assessment he has made of the uniformity of availability of human epidermal growth factor receptor 2 (HER 2) testing across the country;
26 Oct 2004 : Column 1197W
and what steps he is taking to ensure that there is equitable provision of HER2 testing across the country; [193064]
(2) what measures are being put in place by his Department to ensure that the quality of human epidermal growth factor receptor 2 (HER2) testing is of a uniformly high standard across England; and what plans his Department has to collect data on HER2 testing; [193065]
(3) what plans his Department has in place for auditing and monitoring the uptake of human epidermal growth factor receptor 2 (HER2) testing. [193066]
Miss Melanie Johnson: The Department does not collect information about the availability or quality of testing for human epidermal growth factor receptor 2 (HER2) and has no plans to collect such data or audit and monitor the use of this test.
| Next Section | Index | Home Page |